Beneficient BENF

1.46 0.01 0.69% as of 25 Sep
Market cap
$24.9M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.04
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — 3
Sell — — — — — — — — — — — —
Insider Ownership 99.12%

Capital & Financial Ratios

Market Cap 24.88
Revenue —
Net Income 0.00
Free Cash Flow (28.67)
Net Debt 149.00
Current Ratio 0.86
Debt/Equity 0.41
P/E ratio 0.00
P/S ratio 0.00
P/B ratio 1.02
Past 5Y EPS Growth —
This Y EPS Growth 88.16%
Next Y EPS Growth 90.83%
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2020 2021 2022 2023
Cash 0 1 0 10
Receivables — — — —
Inventory — — — —
Other — 1 0 —
0 2 1 —
2019 2020 2021 2022
Payables — — — —
ST’ Debt — — — —
Other — 0 0 1
— 0 0 1
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — —
Cash Flow — — —
Earnings — 0.00% 0.00%
Book Value — — 0.00%

Revenue

Mar Jun Sep Dec Year
’26 — — — — —
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 — — — — —
’23 0 (14) (13) — (95)
’22 0 0 0 (1) (2)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 — — — — —
’23 0 (14) (13) — (95)
’22 0 0 0 (1) (2)
in millions of $ · fiscal quarters ending in the months shown

EPS

Jun Sep Dec Mar Year
’26 (0.47) — — — —
’26 (57.52) (2.96) 0.04 (3.72) (14.02)
’25 1.36 0.24 (10.56) — 68.08
’24 — — — — (5.39k)
’23 (5.49) (928.00) (1.27k) — (1.94)
’22 0.12 0.01 0.04 0.14 0.32
’21 — — 0.15 — 0.15
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
— — — — 6,291.20 6,304.00 231.04 4.83 1.75 0.50

Analyst estimates 2027–2029

Powerpack
Low Price
— — — — 6,348.80 6,720.00 10,560.00 326.40 12.48 7.68
High Price
— — — — — — — — — —
Employees
— — — — — — 0 — — —
Revenue/Emp
— — — — — — 1 — — —
Revenue
— — — — — — 0.00% — — —
Gross Margin
— — — 0 4 9 (253) — — —
EBT
— — — 0.00% 0.00% 0.00% (47,949.24%) — — —
EBT Margin
0 — — 0 4 8 (131) 0 0 0
Net Income
— — — — — — — — — —
Depreciation
— — — 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Revenue/Sh
— — — 0.00 0.15 0.32 (1.94) (5,386.48) 68.08 (14.02)
Earnings/Sh
— — — 0.00 (0.03) (0.07) (1.41) 0.00 0.00 0.00
Cash Flow/Sh
— — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex/Sh
— — — 0.00 (0.03) (0.07) (1.41) 0.00 0.00 0.00
Free CF/Sh
— — — 0.00 7.49 7.80 20.63 0.00 0.00 0.00
Book Value/Sh
— — — 26 26 26 67 0 0 5
Shares
— — — — — — 0.00 — — —
PE Ratio
— — — — — — 0.00 — — —
PS Ratio
— — — — — — 218.31 — — —
PB Ratio
— — — — — — 0.00 — — —
EV/Sales
— — — — — — (2,814.80) — — —
EV/FCF
— — — — (1) (2) (95) — — —
Op' Cash Flow
— — — — — — (2) — — —
Capex
— — — — (1) (2) (95) — — —
FCF
— — — 0 1 0 — — — —
Working Cap'
— — — — — — 151 — — —
Total Debt
— — — 0 (1) 0 141 — — —
Net Debt
— — — 0 195 203 1,392 — — —
Sh' Equity
— — — 0.00% 3.60% 3.87% (8.39%) 22.16% 0.00% 0.00%
ROA
— — — 0.00% 0.00% 0.00% 0.00% — — —
ROIC
— — — 0.00% 3.91% 4.12% (32.37%) 0.00% 0.00% 0.00%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2023 · latest quarter Sep 2023

Beneficient (BENF) key facts

  • Beneficient (BENF) is an Asset Management company in the Financial sector, listed on Nasdaq.
  • Beneficient’s revenue for fiscal 2023 (year ended December 2023) was $528,000.00.
  • As of September 25, 2026, BENF traded at $1.46, a market capitalization of $24.9 million.
  • Return on equity was 0.00% and debt-to-equity 0.41.

Source: company filings (standardised) and stockrow calculations.

Beneficient (BENF) Latest News

News by impact score

Fine-tune

23 Sep

4

Beneficient (NASDAQ: BENF) seeks a consensual resolution with former CEO Brad Heppner to eliminate about $130 million of disputed debt and restructure his remaining equity and contractual interests. Heppner was convicted on May 7, 2026, of securities fraud and wire fraud, with evidence tied to his control of HCLP Nominees, L.L.C. The proposed deal would erase roughly $130 million of HCLP principal and accrued interest, convert Heppner’s equity (including preferred stock with about $850 million liquidation preference) into 162,132 shares of Beneficient Class A common stock, and terminate related contractual arrangements. It would also extinguish about $88 million in amounts Beneficient says are purportedly owed and end Heppner’s Class B stock ownership and associated governance rights. If finalized, the plan would substantially reduce debt and separate Heppner’s interests from the company. Sentencing is set for Oct. 21, 2026; no definitive agreement yet; litigation possible if negotiations fail. Eliminating about $130 million of debt and stripping governance rights could dramatically alter Beneficient's leverage and control dynamics if the settlement is finalized.

4

Beneficient (NASDAQ: BENF) says it has formulated a comprehensive strategy to eliminate the contested HCLP debt and Brad Heppner’s equity interests following Heppner’s May 2026 fraud conviction. The plan includes canceling approximately $130 million of HCLP principal and accrued interest, converting and exchanging all Heppner-related equity (including preferred interests with about $850 million liquidation preference) into 162,132 shares of Beneficient Class A common stock, and terminating or voiding roughly $88 million in remaining agreements and obligations. The resolution would also strip Heppner of Class B stock and associated super-voting rights, unwind governance controls, and remove substantial dilution risk. Beneficient seeks a consensual settlement before Heppner’s sentencing on October 21, 2026, but cautions that no definitive agreement exists and that litigation remains possible. The company emphasizes ongoing operations and aims to transform its balance sheet, simplify its capital structure, and unlock value for stockholders. Eliminating $130M of debt and converting Heppner equity into stock would substantially reset Beneficient's capital structure and equity dilution, with major potential impact if a consensual resolution is reached.

18 Sep

4

Beneficient plans to launch AltLens, an alternative asset portfolio analytics and risk platform designed for family offices and small institutional investors. New product launch expands Beneficient's offerings in alternative assets analytics potentially boosting revenue and market position.

14 Aug

3

Beneficient releases financial results for first quarter of fiscal 2027. Quarterly earnings updates can shift near-term investor views and share price.

29 Jun

4 earnings

Beneficient reported financial results for the fourth quarter and fiscal year ended March 31, 2026. Full-year earnings release supplies key financial metrics that move valuation and sentiment for BENF.

3

Beneficient releases letter to shareholders updating progress on significant corporate issues. Shareholder letter on corporate issues may moderately affect operations and market views but lacks details on transformative outcomes.

25 Jun

3

Beneficient announces first collateral management services engagement. Initial collateral management engagement signals new service line entry with moderate revenue potential.

12 May

5

Beneficient founder Brad Heppner convicted in $150M fraud scheme. Founder conviction in $150M fraud scheme will destroy company credibility and market value.

11 May

4

Beneficient issued a statement addressing the conviction of Heppner, a key figure associated with the company. Heppner's conviction introduces significant legal, reputational, and regulatory risks that could sharply impact Beneficient's market performance and investor sentiment.

7 May

4

Former Beneficient executive with Kansas political ties convicted of fraud in $150M scheme. Conviction of former executive in $150M fraud scheme damages company reputation and investor confidence.

10 Apr

3

Beneficient closes $8.75 million GP primary capital transaction, securing funding through a general partner-led primary issuance. Securing $8.75 million in primary capital bolsters liquidity and financial flexibility, moderately impacting operations and investor sentiment.

19 Feb

4

Beneficient (BENF) F3Q26 earnings recap highlights strengthened business operations, enhanced compliance measures, and improved capital management. Strengthened operations, compliance, and capital management in F3Q26 earnings signal major positive shifts boosting BENF's trajectory and investor sentiment.

18 Feb

4

Beneficient (BENF) released Q3 2026 earnings call summary, detailing financial results, operational highlights, strategic initiatives, and forward-looking guidance for the alternative asset firm. Q3 2026 earnings call reveals key financial metrics and guidance directly shaping Beneficient's trajectory and investor sentiment.

3

Beneficient (BENF) Q3 2026 earnings call highlights navigating operational challenges amid strategic opportunities for growth. Earnings highlights balance challenges and opportunities, moderately influencing financial performance and market sentiment.

17 Feb

4

Beneficient's Q3 earnings call highlighted financial results, operational updates, strategic initiatives, and forward-looking guidance. Q3 earnings highlights disclose financial performance and guidance that significantly sway investor sentiment and stock trajectory.

4

Beneficient reported third quarter fiscal 2026 results. Quarterly financial results represent major disclosures that significantly influence investor sentiment and stock performance.

21 Jan

4

Beneficient (BENF) has received final court approval for its settlement related to the GWG litigation. This settlement resolves ongoing legal disputes and is expected to provide clarity and stability for the company moving forward. The court approval of the settlement is likely to significantly impact Beneficient's future operations and investor sentiment by resolving legal uncertainties.

20 Jan

4

Beneficient (BENF) has announced the early payoff of its debt, which is expected to enhance its financial flexibility and reduce interest expenses. This strategic move aims to strengthen the company's balance sheet and improve its overall financial health. The early repayment reflects Beneficient's commitment to maintaining a robust financial position and could positively influence investor sentiment. The early debt payoff is a significant strategic move that could enhance financial stability and investor confidence.

13 Jan

3

Beneficient (BENF) has expressed support for the SEED Grants program aimed at enhancing rural prosperity in Kansas. The initiative focuses on providing funding to projects that stimulate economic growth and improve quality of life in rural areas. Beneficient's involvement aligns with its commitment to community development and investment in sustainable practices, reflecting its broader mission to foster economic opportunities. Support for rural prosperity initiatives may enhance Beneficient's community engagement and brand reputation, potentially influencing its market positioning.

8 Jan

4

Beneficient (BENF) has entered into a $3 million GP Primary Capital transaction, which is expected to enhance its financial position and support future growth initiatives. This strategic move aims to strengthen the company's capital structure and provide additional resources for its operations. The transaction is a significant strategic move that could enhance Beneficient's financial position and growth potential.

5 Jan

4

Beneficient (BENF) has regained full compliance with Nasdaq listing requirements after addressing previous deficiencies. The company has taken necessary steps to meet the exchange's standards, ensuring its continued presence on the Nasdaq market. This compliance is crucial for maintaining investor confidence and supporting future growth initiatives. Regaining compliance with Nasdaq listing requirements significantly enhances investor confidence and supports the company's strategic positioning.

17 Dec

3

Beneficient has appointed Peter T. Cangany Jr. as the new Chairman of the Board. Cangany brings extensive experience in finance and investment management, having held leadership roles in various financial institutions. His appointment is expected to enhance the company's strategic direction and governance. Leadership changes can moderately influence company strategy and market perception.

11 Dec

3

Beneficient (BENF) has announced a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. This decision comes as the company aims to enhance its stock price and maintain its listing on the exchange. The reverse split is intended to consolidate shares, thereby increasing the per-share price and aligning with Nasdaq's regulations. The reverse stock split may improve market perception and compliance but does not fundamentally change the company's operations or financial health.

18 Nov

3

Beneficient (BENF) reported its F2Q26 earnings, highlighting a shift away from previous CEO-related issues. The company is now focused on adopting a simpler and more transparent business model, aiming to enhance operational clarity and investor confidence moving forward. The transition to a simpler business model may moderately influence investor sentiment and operational performance.

3

Beneficient (BENF) reported its F2Q26 earnings, highlighting a shift away from previous CEO-related issues. The company is now focused on adopting a simpler and more transparent business model, aiming to enhance operational clarity and investor confidence moving forward. The transition to a simpler business model may moderately influence investor sentiment and operational efficiency.

17 Nov

3

Beneficient (BENF) reported a lower net loss on an adjusted basis for F2Q26, indicating improved financial performance. The company continues to focus on enhancing its operational efficiency and strategic initiatives to drive growth. Investors may view this development positively as it reflects a potential turnaround in the company's financial health. The reduction in net loss suggests a moderately noticeable improvement in financial performance, which could influence investor sentiment.

14 Nov

3

Beneficient (BENF) reported its financial results for the second quarter of fiscal 2026, highlighting key metrics such as revenue growth and operational performance. The company demonstrated resilience in its business model, with increased assets under management and strategic initiatives aimed at enhancing shareholder value. Management provided insights into future growth prospects and ongoing projects, indicating a positive outlook for the remainder of the fiscal year. The reported financial results indicate moderate growth and operational stability, which may influence investor sentiment and market performance.

8 Nov

4

Beneficient (BENF) has announced a strategic partnership aimed at enhancing its service offerings and expanding its market reach. This collaboration is expected to leverage both companies' strengths, potentially leading to improved financial performance and increased customer engagement. The partnership aligns with Beneficient's goals of innovation and growth in the financial services sector. The strategic partnership is likely to significantly enhance Beneficient's market position and operational capabilities.

5 Nov

3

Beneficient (BENF) issued a statement regarding the indictment of CEO Brad Heppner, emphasizing the company's commitment to transparency and cooperation with authorities. The statement reassured stakeholders that the company continues to operate normally and is focused on its business objectives despite the legal challenges faced by its leadership. Beneficient aims to maintain its strategic direction and uphold its responsibilities to clients and investors during this period. The indictment of the CEO may create uncertainty and affect investor sentiment, but the company's operations are expected to continue without major disruption.

4 Nov

4

Brad Heppner, the founder of Beneficient (BENF), has been charged with securities fraud. The allegations include misleading investors and misappropriating funds. The charges could have significant legal and financial repercussions for the company, potentially affecting its operations and market perception. The securities fraud charges against the founder are likely to significantly impact investor sentiment and the company's future performance.

stockrow.com/BENF · Data as of Sep 30, 2023 · For information only; not investment advice. · © 2026 stockrow.com